Anybody can write a Seeking Alpha article. Its unfortunate that people are too lazy/stupid to know what they are writing. Should be pulled from writing future articles.
The market doesn't seem very content with the CEO selection due to the word "interim". Stating the obvious the market does not like uncertainty, the word interim does not remove this. However, I like what they are doing. They cut staff, instead of waiting to see what FDA says. This is 2 million plus in savings a year. Interim CEO with experience of FDA approval and marketing. I really liked King, but liking someone does not always mean they make the best decisions, just like a head coach. Someone has to take the fallout. The good news is Perceptive did not bail on this story. We still have European approval this year (hopefully) and potential partnerships. After discussions with the several (over 10) nurses over the course of the last year, there is a market need for their product. Will be a game changer eventually, just short term pain.(pun intended).
Adam will you do every poster on this board a favor and go away? You are either a #$%$ troll or the biggest waste of cyberspace there is.
Once uncertainty is removed from next steps with FDA, that will paint a clearer picture of what they will need. They have milestone payments and potential partnerships that could reduce the funds required.
As you are already aware, they were waiting for the military contract to begin phase 3. They set a deadline of end of Q1, as the contract gets finalized. So now they begin phase 3.
Now you are speculating they won't provide top line results by end of year. Sorry got bigger fish to fry than have a discussion of such. Surprised you didn't focus on European approval and the impact of the FDA, if any. Or is that your next thread?
Why this company is getting punished is due to lack of leadership. I orginally questioned King's departure, but not anymore. Hopefully BOD has long weekend, and we have CEO next week.
I think the margin selling will subside and could see some for 4's filed. We had some institutions selling no doubt, but hoping perceptive wasn't one of them. New cycle over? Not sure I am on the same page as you there.
1. New CEO (company is under some pressure obv)
2. Gov contract on 04
3. Form 4's
4. Update on meeting (when) w/ FDA
5. Just leaving the door open, again they are under pressure from some big holders
A new CEO could potentially add value here. King being exited out the building might also bring some value.
So hopefully military funding for 04, still have Europe, but not sure the minutes from the FDA will do anything. I think everyone will be in a wait and see with this until submission.
Adam I am guessing you are trolling the board, but in the rare situation you are not, you are saying the same thing over and over. Most of the folks posting have been here about 2 years longer than you.
Mabye they showed up with bags over their head.... I keep hearing "No, we didn't ask about the clinical trials" from the cc over and over again.
The problem with this is according to last report they were going to fund the entire phase 3. Now we are looking at hopefully half. You get a higher pps when management has high credibility. And King is still there? Will be surprised if this doesn't break 4 before this is over.
Agreed. There has been late day buying every for last 4 trading days.. Hopefully that continues today. Would like to see the volume pick up a little bit....
"They" want you out before the run up.... it is frustrating but getting in and making money not supposed to be easy. Do you think these breakouts are caused by retail investors?